Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy

Cytokine therapy, involving interleukin-15 (IL-15), is a promising strategy for cancer immunotherapy. However, clinical application has been limited due to severe toxicity and the relatively low immune response rate, caused by wide distribution of cytokine receptors, systemic immune activation and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaiyuan, Zhang, Xuanbo, Ye, Hao, Wang, Xia, Fan, Zhijin, Lu, Qi, Li, Songhao, Zhao, Jian, Zheng, Shunzhe, He, Zhonggui, Ni, Qianqian, Chen, Xiaoyuan, Sun, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598200/
https://www.ncbi.nlm.nih.gov/pubmed/37875481
http://dx.doi.org/10.1038/s41467-023-42155-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598200/
https://www.ncbi.nlm.nih.gov/pubmed/37875481
http://dx.doi.org/10.1038/s41467-023-42155-z

Ejemplares similares